checkAd

     119  0 Kommentare Allakos Initiates Patient Recruitment for AK002 Registrational Studies - Seite 4

    Source: Allakos Inc.

    CONTACT: Investor Contact:
    Adam Tomasi, President and COO
    ir@allakos.com
    
    Media Contact:
    Denise Powell
    denise@redhousecomms.com


    globenewswire
    0 Follower
    Autor folgen
    Seite 4 von 4

    Verfasst von globenewswire
    Allakos Initiates Patient Recruitment for AK002 Registrational Studies - Seite 4 - Phase 3 study in eosinophilic gastritis and/or eosinophilic duodenitis and Phase 2/3 study in eosinophilic esophagitis -  - Top-line safety and efficacy results from both studies expected in the second half of 2021 - REDWOOD CITY, Calif., …